Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
0.108
+0.003 (2.38%)
At close: Nov 22, 2024, 4:00 PM
0.102
-0.006 (-5.39%)
After-hours: Nov 22, 2024, 7:59 PM EST
Eyenovia Revenue
Eyenovia had revenue of $1.63K in the quarter ending September 30, 2024, with 35.64% growth. This brings the company's revenue in the last twelve months to $31.83K, up 2,557.10% year-over-year. In the year 2023, Eyenovia had annual revenue of $3.79K.
Revenue (ttm)
$31.83K
Revenue Growth
+2,557.10%
P/S Ratio
185.20
Revenue / Employee
$558
Employees
57
Market Cap
9.30M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Star Equity Holdings | 50.38M |
Precipio | 17.41M |
Jaguar Health | 10.48M |
Evogene | 7.48M |
COSCIENS Biopharma | 4.83M |
Onconetix | 1.46M |
Vaccinex | 388.00K |
EYEN News
- 1 day ago - Eyenovia Provides Update on Restructuring Efforts - GlobeNewsWire
- 8 days ago - Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline - Benzinga
- 8 days ago - Eyenovia to discontinue late-stage study for eye drug - Reuters
- 8 days ago - Eyenovia Provides Update on Phase 3 CHAPERONE Study - GlobeNewsWire
- 10 days ago - Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th - GlobeNewsWire
- 5 weeks ago - Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo - GlobeNewsWire
- 7 weeks ago - Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device - GlobeNewsWire